Live Quote · NASDAQMIROHealthcare· Biotechnology

Miromatrix Medical Inc.

$3.39 0.59%(+$0.02)
TickerSpark Score
66/100
Solid
53
Valuation
40
Profitability
55
Growth
84
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MIRO research report →

52-Week Range72% of range
Low
$0.91
Current
$3.39
High
$4.35
Company Overviewwww.miromatrix.com

About the company

Miromatrix Medical Inc. is a life sciences company dedicated to pioneering a novel technology for bioengineering organs that are fully transplantable. Central to its innovative work is a proprietary platform utilizing a two-stage method involving decellularization and recellularization.

CEO
Jeffrey James Ross
IPO
2021
Employees
76
HQ
Eden Prairie, MN, US

Price Chart

+21.07% · this period
$3.49$2.21$0.92Dec 22Jun 27Dec 22
Valuation
Market Cap
$92.95M
P/E
-2.34
P/S
97.49
P/B
2.69
EV/EBITDA
-3.07
Div Yield
0.00%
Profitability
Gross Margin
47.56%
Op Margin
-3172.17%
Net Margin
-3147.22%
ROE
-74.80%
ROIC
-99.98%
Growth & Income
Revenue
$953.47K · 2783.54%
Net Income
$-30,007,832 · -100.64%
EPS
$-1.45 · -98.63%
Op Income
$-30,245,734
FCF YoY
-52.51%
Performance & Tape
52W High
$4.35
52W Low
$0.91
50D MA
$2.48
200D MA
$1.72
Beta
0.01
Avg Volume
163.02K

Get TickerSpark's AI analysis on MIRO

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Dec 12, 23UNITED THERAPEUTICS Corpother0
Dec 12, 23Heine Lisa Wippermanother66,943
Dec 13, 23Heine Lisa Wippermansell67,413
Dec 12, 23Maag Peterother62,092
Dec 13, 23Maag Petersell58,368
Dec 12, 23ERB JOHN Lother56,260
Dec 13, 23ERB JOHN Lsell54,201
Dec 13, 23ERB JOHN Lsell25,000
Dec 12, 23BUCKMAN PAULother52,593
Dec 13, 23BUCKMAN PAULsell54,201
Coverage · MIRO

Our MIRO coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on MIRO yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate MIRO report →
Internal Compare

Similar companies

Peers in the same neighborhood.